Combined oral contraceptives (COC) and progestogens are widely used for the treatment of endometriosis. The objective of the study is to compare the efficacy of dienogest 2 mg vs continuous oral levonorgestrel/EE (levonorgestrel 0.1 mg/ethinyl estradiol 0.02 mg) on ovarian endometriomas, deep infiltrating endometriosis (DIE), chronic pelvic pain (CPP), dyspareunia, analgesic use, quality of life (QoL), compliance and side effects.
Dienogest versus continuous oral levonorgestrel/EE in patients with endometriosis: what's the best choice? / Piacenti, Ilaria; Viscardi, Maria Federica; Masciullo, Luisa; Sangiuliano, Chiara; Scaramuzzino, Sara; Piccioni, Maria Grazia; Muzii, Ludovico; Benedetti Panici, Pierluigi; Porpora, Maria Grazia. - In: GYNECOLOGICAL ENDOCRINOLOGY. - ISSN 1473-0766. - (2021), pp. 471-475. [10.1080/09513590.2021.1892632]
Dienogest versus continuous oral levonorgestrel/EE in patients with endometriosis: what's the best choice?
Piacenti, Ilaria
;Viscardi, Maria Federica;Masciullo, Luisa;Sangiuliano, Chiara;Scaramuzzino, Sara;Piccioni, Maria Grazia;Muzii, Ludovico;Benedetti Panici, Pierluigi;Porpora, Maria Grazia
2021
Abstract
Combined oral contraceptives (COC) and progestogens are widely used for the treatment of endometriosis. The objective of the study is to compare the efficacy of dienogest 2 mg vs continuous oral levonorgestrel/EE (levonorgestrel 0.1 mg/ethinyl estradiol 0.02 mg) on ovarian endometriomas, deep infiltrating endometriosis (DIE), chronic pelvic pain (CPP), dyspareunia, analgesic use, quality of life (QoL), compliance and side effects.| File | Dimensione | Formato | |
|---|---|---|---|
|
Piacenti_Dienogest_2021.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
775.97 kB
Formato
Adobe PDF
|
775.97 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
